30th Healthcare Barcelona Investment Forum
Col·legi de Metges de Barcelona, Barcelona Activa – Ajuntament de Barcelona, ESADE-BAN and Biocat
On March 31 at 4:30 p.m., the 30th Barcelona Healthcare Investment Forum will be held in a hybrid format, co-organized by the Barcelona Medical Association, Barcelona Activa – Barcelona City Council, ESADE-BANDO and Biocat. The Forum has positioned itself as a benchmark in the Catalan biomedical ecosystem, promoting innovation and entrepreneurship among the group with the aim of bringing together entrepreneurs and investors in the health sector.
The four organizers have appointed a project selection committee which will be made up of: Nadia Pons (Director of the Health Entrepreneurship Program en Medical Association of Barcelona), Fernando Zallo (Director at ESADE BAN), Jaume Baró (Business Services Director at Barcelona Activa - Ajuntament de Barcelona) and Núria Martí (Director of Innovation and Business Development at Biocat).
All entrepreneurs with projects in Biotechnology, Medical Devices, Health Services and Information Technologies related to health, can submit their application until March 10. In addition, if you present your project before February 28, you will be eligible for financial mentoring with a specialist from the ESADE BANDO network. In the mentoring, topics such as: the preparation of the investment round, the review of the valuation, the review of the key aspects of the financial plan and the review of the commercial strategy* will be worked on.
* The mentories will be subject to the availability of the mentors and the projects will be prioritized in order of arrival.
The first Healthcare Investment Forum took place in 2010 and, since then and with data obtained up to the 22nd edition, it has served as a springboard for more than 200 companies, after a selection process in which more than 600 projects have been studied. The companies that have managed to exhibit at the Forum have subsequently, directly or indirectly, raised a total investment figure of 40 million euros.